Infinity Pharmaceuticals has scuttled a plan to combine with MEI Pharma, whose shareholders rebuffed the merger over the weekend, the company announced Monday morning. The announcement comes days ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”), a clinical-stage biotechnology company developing eganelisib, a ...
A Massachusetts biotech is clearing out its C-suite in the wake of a failed merger agreement that had already cost 21 jobs. Infinity Pharmaceuticals Inc. (Nasdaq: INFI) CEO Adelene Perkins, chief ...
The board of MEI Pharma (US:MEIP), a San Diego-based oncology company, is under fire from prominent shareholders who argue that a proposed merger with Infinity Pharmaceuticals (US:INFI) undervalues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback